Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics

Vorschaubild
Autor:innen
Wyttenbach, Nicole
Alsenz, Jochem
Grassmann, Olaf
Autor:in (Körperschaft)
Publikationsdatum
30.11.2016
Typ der Arbeit
Studiengang
Sammlung
Institut für Pharma Technology
Komplettanzeige
Typ
01A - Beitrag in wissenschaftlicher Zeitschrift
Herausgeber:innen
Herausgeber:in (Körperschaft)
Betreuer:in
Übergeordnetes Werk
Journal of Pharmaceutical and Biomedical Analysis
Themenheft
DOI der Originalpublikation
https://doi.org/10.1016/j.jpba.2016.08.028
URI
http://hdl.handle.net/11654/23743
Link
Reihe / Serie
Reihennummer
Jahrgang / Band
131
Ausgabe / Nummer
Seiten / Dauer
195-201
Patentnummer
Verlag / Herausgebende Institution
Elsevier
Verlagsort / Veranstaltungsort
Auflage
Version
Programmiersprache
Abtretungsempfänger:in
Praxispartner:in/Auftraggeber:in
Zusammenfassung
Many pharmaceutical compounds exhibit polymorphism, which may result in solvent-mediated phase transformations. Since the polymorphic form has an essential influence on physicochemical characteristics such as solubility or dissolution rate, it is crucial to know the exact polymorphic composition of a drug throughout pharmaceutical development. This study addressed the need to perform quantitative X-ray analysis of polymorphic mixtures on a 96-well scale (MixRay). A calibration of polymorphic mixtures (anhydrate and hydrate) was performed with three model drugs, caffeine, piroxicam, and testosterone, and linear correlations were obtained for all compounds. The MixRay approach for piroxicam was applied to a solubility and residual solid screening assay (SORESOS) to quantify the amount of hydrate and anhydrate corresponding to kinetic bulk concentrations. Changes in these drug concentrations correlated well with the kinetic changes in the residual solid. The influence of excipients on the solid state and kinetic concentrations of piroxicam was also studied. Excipients strongly affected polymorphic transformation kinetics of piroxicam and concentrations after 24h depended on the excipient used. The new calibration X-ray method combined with bulk concentration analysis provides a valuable tool for both pharmaceutical profiling and early formulation development.
Schlagwörter
Miniaturized assay, Quantitative analysis, Solid state transformation, X-ray diffraction
Fachgebiet (DDC)
Projekt
Veranstaltung
Startdatum der Ausstellung
Enddatum der Ausstellung
Startdatum der Konferenz
Enddatum der Konferenz
Datum der letzten Prüfung
ISBN
ISSN
0731-7085
1873-264X
Sprache
Englisch
Während FHNW Zugehörigkeit erstellt
Ja
Zukunftsfelder FHNW
Publikationsstatus
Veröffentlicht
Begutachtung
Peer-Review der ganzen Publikation
Open Access-Status
Lizenz
Zitation
Kirchmeyer, W., Wyttenbach, N., Alsenz, J., Kuentz, M., & Grassmann, O. (2016). Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics. Journal of Pharmaceutical and Biomedical Analysis, 131, 195–201. https://doi.org/10.1016/j.jpba.2016.08.028
Komplettanzeige